Delivery Order SPE2DR25D1201-SPE2DR26FAJRF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Brilinta 60 mg tablets (60-count units) valued at $1,211.20 under a firm fixed-price contract type. This delivery order, which is a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX, valued at $999.999 billion through December 2026), represents a competitively awarded, non-set-aside procurement. The place...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,720.95 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count packages) under a firm fixed-price contract type. The award, issued on July 30, 2025, with an ultimate completion date of July 31, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Brilinta 90 mg tablets in a 60-count configuration. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $10,236.96 and an ultimate completion date of September 22, 2025. The award was issued on September 19, 2025, with no set-aside designation applied. As a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Brilinta 60 mg tablets (60-count) on November 3, 2025, with an ultimate completion date of November 4, 2025. This firm fixed price delivery order, valued at $1,516.38, represents a non-competitive set-aside award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,188.39 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count packaging) on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Brilinta 60 mg tablets (60-count units) under a firm fixed-price contract type. The order, valued at $2,230.62, was competitively awarded without set-aside designation and is scheduled for completion by November 5, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply delivery. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,501.34 to AmerisourceBergen Drug Corp for the supply of Brilinta (ticagrelor) 90 mg tablets in a 60-tablet package. The contract, issued on August 6, 2025, with an ultimate completion date of August 7, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under a larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Brilinta 60 mg tablets (60-count packages) on September 26, 2025, with a ceiling value of $1,642.85 and an ultimate completion date of September 29, 2025. This competitively awarded, firm fixed-price delivery order is non-set-aside and will be performed at the contractor's Conshohocken, Pennsylvania facility. The contract represents a pediatric or continuation order under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60 count) on July 30, 2025, with an ultimate completion date of July 31, 2025. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $2,044.86 and is classified as a non-set-aside contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count packages) under a firm fixed-price contract valued at $2,134.02. The order was competitively awarded without a set-aside designation and carries an ultimate completion date of July 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location. This delivery order represents a child...
- SPE2DR25D1201Indefinite Delivery Contract
- SPE2DR25D1201-SPE2DR26FAJRFDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Brilinta 60 mg tablets (60-count units) under a firm fixed-price contract with a ceiling value of $1,758.96. The award, issued on November 3, 2025, is set to be completed by November 4, 2025. This delivery order represents a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, was selected through competitive procurement with no set-aside designation applied. The company's extensive federal contract portfolio demonstrates its established capability to supply pharmaceutical products and medical commodities to military and veteran healthcare systems. This delivery order for Brilinta—a cardiovascular medication—is one of numerous pharmaceutical procurements the company fulfills through the DLA Medical Supply Chain, supporting the Defense Health Agency and other federal healthcare customers worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 11/3/25 |